Log In
BCIQ
Print this Print this
 

SENS-218

  Manage Alerts
Collapse Summary General Information
Company Sensorion S.A.
DescriptionSerotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationVestibular disorders
Indication DetailsTreat inner ear dysfunction due to vestibular damage by a lesion; Treat vestibular or cochlear lesions of the inner ear
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today